Menu
AstraZeneca headquarters
AstraZeneca has announced it will tighten its 340B contract pharmacy restrictions for all covered entity types.

AstraZeneca Tightens Contract Pharmacy Restrictions to Require Claims Data Submission

Bella Czajkowski, National Correspondent Views
Beginning Oct. 1, AstraZeneca will tighten its 340B contract pharmacy restrictions to require claims data on 340B utilization at contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.